Debt-to-equity of Ernexa Therapeutics Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ernexa Therapeutics Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Ernexa Therapeutics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 540%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Ernexa Therapeutics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 540% +918% 30 Sep 2025
Q2 2025 -157% +3159% +95% 30 Jun 2025
Q1 2025 -211% -3279% -107% 31 Mar 2025
Q4 2024 -296% -1155% -134% 31 Dec 2024
Q3 2024 -378% -785% -193% 30 Sep 2024
Q2 2024 -3315% -3543% -1559% 30 Jun 2024
Q1 2024 3068% +2971% +3037% 31 Mar 2024
Q4 2023 859% +760% +768% 31 Dec 2023
Q3 2023 407% +335% +460% 30 Sep 2023
Q2 2023 227% +157% +224% 30 Jun 2023
Q1 2023 98% +35% +56% 31 Mar 2023
Q4 2022 99% +29% +42% 31 Dec 2022
Q3 2022 73% -8% -9.9% 30 Sep 2022
Q2 2022 70% -6% -7.4% 30 Jun 2022
Q1 2022 63% -30% -32% 31 Mar 2022
Q4 2021 70% +13% +22% 31 Dec 2021
Q3 2021 81% +17% +27% 30 Sep 2021
Q2 2021 76% -4% -5.6% 30 Jun 2021
Q1 2021 92% -14% -13% 31 Mar 2021
Q4 2020 57% -66% -54% 31 Dec 2020
Q3 2020 64% -69% -52% 30 Sep 2020
Q2 2020 80% -50% -38% 30 Jun 2020
Q1 2020 106% -28% -21% 31 Mar 2020
Q4 2019 123% -21% -15% 31 Dec 2019
Q3 2019 133% -33% -20% 30 Sep 2019
Q2 2019 130% -54% -29% 30 Jun 2019
Q1 2019 134% -66% -33% 31 Mar 2019
Q4 2018 145% -55% -27% 31 Dec 2018
Q3 2018 166% -54% -25% 30 Sep 2018
Q2 2018 184% -95% -34% 30 Jun 2018
Q1 2018 200% -155% -44% 31 Mar 2018
Q4 2017 199% -259% -56% 31 Dec 2017
Q3 2017 220% -247% -53% 30 Sep 2017
Q2 2017 279% -87% -24% 30 Jun 2017
Q1 2017 355% +77% +28% 31 Mar 2017
Q4 2016 458% +254% +124% 31 Dec 2016
Q3 2016 466% +314% +206% 30 Sep 2016
Q2 2016 366% +251% +219% 30 Jun 2016
Q1 2016 278% +187% +205% 31 Mar 2016
Q4 2015 204% +123% +152% 31 Dec 2015
Q3 2015 153% +80% +110% 30 Sep 2015
Q2 2015 115% +46% +68% 30 Jun 2015
Q1 2015 91% +24% +36% 31 Mar 2015
Q4 2014 81% +20% +34% 31 Dec 2014
Q3 2014 73% +14% +25% 30 Sep 2014
Q2 2014 68% +7% +11% 30 Jun 2014
Q1 2014 67% +1% +1.7% 31 Mar 2014
Q4 2013 61% -8% -12% 31 Dec 2013
Q3 2013 58% -16% -22% 30 Sep 2013
Q2 2013 61% -11% -16% 30 Jun 2013
Q1 2013 66% -3% -4.6% 31 Mar 2013
Q4 2012 69% 31 Dec 2012
Q3 2012 74% 30 Sep 2012
Q2 2012 73% 30 Jun 2012
Q1 2012 69% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.